Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
aut.relation.endpage | 894 | |
aut.relation.issue | 5 | en_NZ |
aut.relation.journal | Pharmaceutics | en_NZ |
aut.relation.startpage | 894 | |
aut.relation.volume | 14 | en_NZ |
aut.researcher | Li, Yan | |
dc.contributor.author | He, J | en_NZ |
dc.contributor.author | Biswas, R | en_NZ |
dc.contributor.author | Bugde, P | en_NZ |
dc.contributor.author | Li, J | en_NZ |
dc.contributor.author | Liu, D-X | en_NZ |
dc.contributor.author | Li, Y | en_NZ |
dc.date.accessioned | 2022-04-28T04:18:56Z | |
dc.date.available | 2022-04-28T04:18:56Z | |
dc.description.abstract | In recent years, sequence-specific clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) systems have been widely used in genome editing of various cell types and organisms. The most developed and broadly used CRISPR-Cas system, CRISPR-Cas9, has benefited from the proof-of-principle studies for a better understanding of the function of genes associated with drug absorption and disposition. Genome-scale CRISPR-Cas9 knockout (KO) screen study also facilitates the identification of novel genes in which loss alters drug permeability across biological membranes and thus modulates the efficacy and safety of drugs. Compared with conventional heterogeneous expression models or other genome editing technologies, CRISPR-Cas9 gene manipulation techniques possess significant advantages, including ease of design, cost-effectiveness, greater on-target DNA cleavage activity and multiplexing capabilities, which makes it possible to study the interactions between membrane proteins and drugs more accurately and efficiently. However, many mechanistic questions and challenges regarding CRISPR-Cas9 gene editing are yet to be addressed, ranging from off-target effects to large-scale genetic alterations. In this review, an overview of the mechanisms of CRISPR-Cas9 in mammalian genome editing will be introduced, as well as the application of CRISPR-Cas9 in studying the barriers to drug delivery. | en_NZ |
dc.identifier.citation | Pharmaceutics, 14(5), 894. https://doi.org/10.3390/pharmaceutics14050894 | |
dc.identifier.doi | 10.3390/pharmaceutics14050894 | en_NZ |
dc.identifier.issn | 1999-4923 | en_NZ |
dc.identifier.uri | https://hdl.handle.net/10292/15094 | |
dc.language | en | en_NZ |
dc.publisher | MDPI AG | en_NZ |
dc.relation.uri | https://www.mdpi.com/1999-4923/14/5/894 | |
dc.rights | © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | |
dc.rights.accessrights | OpenAccess | en_NZ |
dc.subject | CRISPR-Cas9; Blood-brain barrier; Intestinal epithelial barrier; Drug permeability | |
dc.title | Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery | en_NZ |
dc.type | Journal Article | |
pubs.elements-id | 453694 | |
pubs.organisational-data | /AUT | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science/School of Public Health & Interdisciplinary Studies | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science/School of Public Health & Interdisciplinary Studies/Biosciences Department | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science/School of Science | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science/School of Science/Biomedicine & Medical Diagnostics Department | |
pubs.organisational-data | /AUT/PBRF | |
pubs.organisational-data | /AUT/PBRF/PBRF Health and Environmental Sciences | |
pubs.organisational-data | /AUT/PBRF/PBRF Health and Environmental Sciences/HA Science 2018 PBRF | |
pubs.organisational-data | /AUT/PBRF/PBRF Health and Environmental Sciences/HI Interprofessional 2018 PBRF |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery.pdf
- Size:
- 1.34 MB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
Loading...
- Name:
- AUT Grant of Licence for Tuwhera Jun 2021.pdf
- Size:
- 360.95 KB
- Format:
- Adobe Portable Document Format
- Description: